Zhao Y - Search Results

1

The cellular uptake and cytotoxic effect of silver nanoparticles on chronic myeloid leukemia cells.

Guo D, Zhao Y, Zhang Y, Wang Q, Huang Z, Ding Q, Guo Z, Zhou X, Zhu L, Gu N. Guo D, et al. Among authors: zhao y. J Biomed Nanotechnol. 2014 Apr;10(4):669-78. doi: 10.1166/jbn.2014.1625. J Biomed Nanotechnol. 2014. PMID: 24734519

2

Modulating the Growth and Imatinib Sensitivity of Chronic Myeloid Leukemia Stem/Progenitor Cells with Pullulan/MicroRNA Nanoparticles In Vitro.

Ma W, Liu J, Xie J, Zhang X, Zhou H, Yao H, Zhang W, Guo D, Zhu L, Xiao L, Wu D, Xu H, Chen S, Zhao Y. Ma W, et al. Among authors: zhao y. J Biomed Nanotechnol. 2015 Nov;11(11):1961-74. doi: 10.1166/jbn.2015.2147. J Biomed Nanotechnol. 2015. PMID: 26554155

3

Activation of autophagy by elevated reactive oxygen species rather than released silver ions promotes cytotoxicity of polyvinylpyrrolidone-coated silver nanoparticles in hematopoietic cells.

Zhu L, Guo D, Sun L, Huang Z, Zhang X, Ma W, Wu J, Xiao L, Zhao Y, Gu N. Zhu L, et al. Among authors: zhao y. Nanoscale. 2017 May 4;9(17):5489-5498. doi: 10.1039/c6nr08188f. Nanoscale. 2017. PMID: 28401217

4

Comparison of cellular responses across multiple passage numbers in Ba/F3-BCR-ABL cells induced by silver nanoparticles.

Guo D, Zhang X, Huang Z, Zhou X, Zhu L, Zhao Y, Gu N. Guo D, et al. Among authors: zhao y. Sci China Life Sci. 2012 Oct;55(10):898-905. doi: 10.1007/s11427-012-4382-z. Epub 2012 Oct 31. Sci China Life Sci. 2012. PMID: 23108867

5

Anti-leukemia activity of PVP-coated silver nanoparticles via generation of reactive oxygen species and release of silver ions.

Guo D, Zhu L, Huang Z, Zhou H, Ge Y, Ma W, Wu J, Zhang X, Zhou X, Zhang Y, Zhao Y, Gu N. Guo D, et al. Among authors: zhao y. Biomaterials. 2013 Oct;34(32):7884-94. doi: 10.1016/j.biomaterials.2013.07.015. Epub 2013 Jul 19. Biomaterials. 2013. PMID: 23876760

6

Growth arrest specific 2 is up-regulated in chronic myeloid leukemia cells and required for their growth.

Zhou H, Ge Y, Sun L, Ma W, Wu J, Zhang X, Hu X, Eaves CJ, Wu D, Zhao Y. Zhou H, et al. Among authors: zhao y. PLoS One. 2014 Jan 21;9(1):e86195. doi: 10.1371/journal.pone.0086195. eCollection 2014. PLoS One. 2014. PMID: 24465953 Free PMC article.

7

Stem cell biomarkers in chronic myeloid leukemia.

Jiang X, Zhao Y, Forrest D, Smith C, Eaves A, Eaves C. Jiang X, et al. Among authors: zhao y. Dis Markers. 2008;24(4-5):201-16. doi: 10.1155/2008/146871. Dis Markers. 2008. PMID: 18525114 Free PMC article. Review.

8

Oncogenic heterogeneous nuclear ribonucleoprotein D-like modulates the growth and imatinib response of human chronic myeloid leukemia CD34⁺ cells via pre-B-cell leukemia homeobox 1.

Ji D, Zhang P, Ma W, Fei Y, Xue W, Wang Y, Zhang X, Zhou H, Zhao Y. Ji D, et al. Among authors: zhao y. Oncogene. 2020 Jan;39(2):443-453. doi: 10.1038/s41388-019-0998-9. Epub 2019 Sep 5. Oncogene. 2020. PMID: 31488872

9

Chronic myeloid leukemia stem cells possess multiple unique features of resistance to BCR-ABL targeted therapies.

Jiang X, Zhao Y, Smith C, Gasparetto M, Turhan A, Eaves A, Eaves C. Jiang X, et al. Among authors: zhao y. Leukemia. 2007 May;21(5):926-35. doi: 10.1038/sj.leu.2404609. Epub 2007 Mar 1. Leukemia. 2007. PMID: 17330101

10

Expression of the leukemic prognostic marker CD7 is linked to epigenetic modifications in chronic myeloid leukemia.

Rogers SL, Zhao Y, Jiang X, Eaves CJ, Mager DL, Rouhi A. Rogers SL, et al. Among authors: zhao y. Mol Cancer. 2010 Feb 22;9:41. doi: 10.1186/1476-4598-9-41. Mol Cancer. 2010. PMID: 20175919 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87,465 results

Search Page

Filters